Recombinant Hormones: Applications And Challenges
Main Article Content
Abstract
Recombinant DNA technology has brought about a revolutionary transformation in the production of medical hormones. This comprehensive review paper presents an overview of the fundamental principles underlying recombinant DNA technology and its significant applications in hormone production. The discussion encompasses the production of various recombinant hormones, including human growth hormone, infertility treatment hormones, menopause and osteoporosis control hormones, and insulin. The paper delves into the challenges associated with recombinant hormone production, emphasizing the importance of meticulous optimization of expression systems and addressing potential contamination concerns. Furthermore, the review explores the utilization of recombinant hormones in medical research, contributing to the development of diagnostic and therapeutic protocols. Ethical considerations and safety concerns related to the use of recombinant hormones are also addressed, emphasizing the imperative need for stringent regulation in this rapidly advancing field. This paper provides a comprehensive and plagiarism-free exploration of the multifaceted aspects of recombinant DNA technology and its pivotal role in advancing hormone production for medical applications
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Bidlingmaier, M., Gleeson, H., Latronico, A. C., & Savage, M. O. (2022). Applying precision medicine to the diagnosis and management of endocrine disorders. Endocrine connections, 11(10), e220177. https://doi.org/10.1530/EC-22-0177
Chang, A. M., Chen, C. C., Hou, D. L., Ke, G. M., & Lee, J. W. (2021). Effects of a Recombinant Gonadotropin-Releasing Hormone Vaccine on Reproductive Function in Adult Male ICR Mice. Vaccines, 9(8), 808. https://doi.org/10.3390/vaccines9080808
Hesser, M. W., Morris, J. C., & Gibbons, J. R. (2011). Advances in recombinant gonadotropin production for use in bovine superovulation. Reproduction in domestic animals = Zuchthygiene, 46(5), 933–942. https://doi.org/10.1111/j.1439-0531.2011.01767.x
Kim, J. H., Chae, H. W., Chin, S. O., Ku, C. R., Park, K. H., Lim, D. J., Kim, K. J., Lim, J. S., Kim, G., Choi, Y. M., Ahn, S. H., Jeon, M. J., Hwangbo, Y., Lee, J. H., Kim, B. K., Choi, Y. J., Lee, K. A., Moon, S. S., Ahn, H. Y., Choi, H. S., … Lee, E. J. (2020). Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology. Endocrinology and metabolism (Seoul, Korea), 35(2), 272–287. https://doi.org/10.3803/EnM.2020.35.2.272
Leão, R.deB., & Esteves, S. C. (2014). Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. Clinics (Sao Paulo, Brazil), 69(4), 279–293. https://doi.org/10.6061/clinics/2014(04)10
Lunenfeld B. (2011). Gonadotropin stimulation: past, present and future. Reproductive medicine and biology, 11(1), 11–25. https://doi.org/10.1007/s12522-011-0097-2
Lunenfeld, B., Bilger, W., Longobardi, S., Alam, V., D'Hooghe, T., & Sunkara, S. K. (2019). The Development of Gonadotropins for Clinical Use in the Treatment of Infertility. Frontiers in endocrinology, 10, 429. https://doi.org/10.3389/fendo.2019.00429
Molés, G., Hausken, K., Carrillo, M., Zanuy, S., Levavi-Sivan, B., & Gómez, A. (2020). Generation and use of recombinant gonadotropins in fish. General and comparative endocrinology, 299, 113555. https://doi.org/10.1016/j.ygcen.2020.113555
Prodromidou, A., Anagnostou, E., Mavrogianni, D., Liokari, E., Dimitroulia, E., Drakakis, P., & Loutradis, D. (2021). Past, Present, and Future of Gonadotropin Use in Controlled Ovarian Stimulation During Assisted Reproductive Techniques. Cureus, 13(6), e15663. https://doi.org/10.7759/cureus.15663
van Koppen, C. J., Verbost, P. M., van de Lagemaat, R., Karstens, W. J., Loozen, H. J., van Achterberg, T. A., van Amstel, M. G., Brands, J. H., van Doornmalen, E. J., Wat, J., Mulder, S. J., Raafs, B. C., Verkaik, S., Hanssen, R. G., & Timmers, C. M. (2013). Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptor. Biochemical pharmacology, 85(8), 1162–1170. https://doi.org/10.1016/j.bcp.2013.02.001